cosibelimab
Drug Details
- Generic Name
- cosibelimab
- Brand Names
- UNLOXCYT
- Application Number
- BLA761297
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- NDC Codes
- 3
- Dosage Forms
- INJECTION, SOLUTION, LIQUID, INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- COSIBELIMAB, COSIBELIMAB-IPDL
Indications and Usage
1. INDICATIONS AND USAGE UNLOXCYT is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation. UNLOXCYT is a programmed death ligand-1 (PD-L1) blocking antibody indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) who are not candidates for curative surgery or curative radiation.